Join
Live feed
·
INSIDERFilingvia Quantisnow
Recro Pharma Inc. logo

SEC Form 4: Enloe J David Jr covered exercise/tax liability with 11,413 shares, decreasing direct ownership by 2% to 498,055 units (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
REPH· Recro Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REPH (Recro Pharma Inc.) and more on Quantisnow.